Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: Different effects of donepezil and rivastigmine

Behavioural Pharmacology

Volumn 22, Issue 1, 2011, Pages 58-70

  Grasing, Kenneth ^a,b   Yang, Yungao ^c   He, Shuangteng ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Acetylcholine; Acetylcholinesterase inhibitors; Cocaine; Donepezil; Rat; Reinforcement; Rivastigmine; Self administration

Indexed keywords

CHOLINESTERASE; COCAINE; DONEPEZIL; RIVASTIGMINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; DRUG POTENCY; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; FASCICULATION; JAW MOVEMENT; NONHUMAN; RAT; REINFORCEMENT; YAWNING;

ANIMALS; BEHAVIOR, ANIMAL; CHOLINESTERASE INHIBITORS; COCAINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; INDANS; MALE; PHENYLCARBAMATES; PIPERIDINES; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 78651409783     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283428cd8     Document Type: Article

References (56)

1. Adem A, Jossan SS, Oreland L (1989). Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase. Neurosci Lett 107:313-317.
2. Adinoff B, Devous MD Sr,Williams MJ, Best SE, Harris TS, Minhajuddin A, et al. (2010). Altered neural cholinergic receptor systems in cocaine-addicted subjects. Neuropsychopharm 35:1485-1499.
3. Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S (2005). Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res 2:307-318.
4. Birks JS, Harvey R (2003). Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev :CD001190.
5. Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR, Winn P (1996). Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16:714-722.
6. Braida D, Virag W, Ottonello F, Sala M (2000). Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit. Pharmacol Res 41:671-677.
7. Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, et al. (2002). Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22:2977-2988.
8. Carmona GN, Schindler CW, Greig NH, Holloway HW, Jufer RA, Cone EJ, Gorelick DA (2005). Intravenous butyrylcholinesterase administration and plasma and brain levels of cocaine and metabolites in rats. Eur J Pharmacol 517:186-190.
9. Cerbai F, Giovannini MG, Melani C, Enz A, Pepeu G (2007). N1phenethylnorcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine. Eur J Pharmacol 572:142-150.
10. Curran-Everett D (2000). Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol 279:R1-R8.
11. Dackis CA, Gold MS (1985). New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 9:469-477.
12. De La Garza R, Mahoney JJ III, Culbertson C, Shoptaw S, Newton TF (2008). The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav 89:200-208.
13. De Vry J, Donselaar I, Van Ree JM (1989). Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. J Pharmacol Exper Therap 251:735-740.
14. Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R (2008). Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging 25:163-174.
15. Dronfield S, Egan K, Marsden CA, Green AR (2000). Comparison of donepezil, tacrine, rivastigmine and metrifonate-induced central and peripheral cholinergically mediated responses in the rat. J Psychopharmacol 14:275-279.
16. Forster GL, Yeomans JS, Takeuchi J, Blaha CD (2002). M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22:RC190.
17. Gerrits MA, Petromilli P, Westenberg HG, Di Chiara G, Van Ree JM (2002). Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Res 924:141-150.
18. Giacobini E (2004). Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacol Res 50:433-440.
19. Gipson CD, Bardo MT (2009). Extended access to amphetamine selfadministration increases impulsive choice in a delay discounting task in rats. Psychopharmacology 207:391-400.
20. Goldstein RA, DesLauriers C, Burda AM (2009). Cocaine: history, social implications, and toxicity - a review. Dis Mon 55:6-38.
21. Grasing K, He S, Yang Y (2008). Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats. Psychopharmacology 196:133-142.
22. Grasing K, He S, Yang Y (2009). Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration. Pharmacol Biochem Behav 94:169-178.
23. Grasing K, Mathur D, Newton TF, DeSouza C (2010). Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend 107:69-75.
24. Grimm JW, Shaham Y, Hope BT (2002). Effect of cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement, and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats. Behav Pharmacol 13:379-388.
25. He S, Yang Y, Mathur D, Grasing K (2008). Selective breeding for intravenous drug self-administration in rats: a pilot study. Behav Pharmacol 19:751-764.
26. Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003). Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci USA 100:6169-6173.
27. Hiranita T, Nawata Y, Sakimura K, Anggadiredja K, Yamamoto T (2006). Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc Natl Acad Sci USA 103:8523-8527.
28. Jossan SS, Adem A,Winblad B, Oreland L (1992). Characterisation of dopamine and serotonin uptake inhibitory effects of tetrahydroaminoacridine in rat brain. Pharmacol Toxicol 71:213-215.
29. Khantzian EJ (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 4:231-244.
30. Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (1999). Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats. Eur J Pharmacol 380:101-107. (Pubitemid 29469519)
31. Li N, He S, Parrish C, Delich J, Grasing K (2003). Differences in morphine and cocaine reinforcement under fixed and progressive ratio schedules; effects of extinction, reacquisition and schedule design. Behav Pharmacol 14:619-630.
32. Liston DR, Nielsen JA, Villalobos A, Chapin D, Jones SB, Hubbard ST, et al. (2004). Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Eur J Pharmacol 486:9-17.
33. Mantsch JR, Ho A, Schlussman SD, Kreek MJ (2001). Predictable individual differences in the initiation of cocaine self-administration by rats under extendedaccess conditions are dose-dependent. Psychopharmacology 157:31-39.
34. Mark GP, Rada P, Pothos E, Hoebel BG (1992). Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. J Neurochem 58:2269-2274.
35. Mateo Y, Lack CM, Morgan D, Roberts DC, Jones SR (2005). Reduced dopamine terminal function and insensitivity to cocaine following cocaine binge self-administration and deprivation. Neuropsychopharm 30:1455-1463.
36. Matsui K, Mishima M, Nagai Y, Yuzuriha T, Yoshimura T (1999). Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat. Drug Metab Dispos 27:1406-1414.
37. Mayorga AJ, Carriero DL, Cousins MS, Gianutsos G, Salamone JD (1997). Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacol Biochem Behav 56:273-279.
38. McQuown SC, Belluzzi JD, Leslie FM (2007). Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol Teratol 29:66-73.
39. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2000). Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmacol 22:609-613.
40. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y (2001). Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats. Eur J Pharmacol 415:157-164.
41. Parsons LH, Koob GF, Weiss F (1995). Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exper Therap 274:1182-1191.
42. Rada PV, Hoebel BG (2001). Aversive hypothalamic stimulation releases acetylcholine in the nucleus accumbens, and stimulation-escape decreases it. Brain Res 888:60-65.
43. Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MD, Thomsen C, Sheardown MJ, et al. (2000). Muscarinic receptor agonists decrease cocaine selfadministration rates in drug-naive mice. Eur J Pharmacol 402:241-246.
44. Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT (1998). Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. Br J Clin Pharmacol 46 (Suppl 1):7-12.
45. Schmitz JM, Mooney ME, Moeller FG, Stotts AL, Green C, Grabowski J (2008). Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend 94:142-150.
46. Snape MF, Misra A, Murray TK, De Souza RJ, Williams JL, Cross AJ, Green AR (1999). A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology 38:181-193.
47. Tanda G, Ebbs AL, Kopajtic TA, Elias LM, Campbell BL, Newman AH, Katz JL (2007). Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-344.
48. Telting-Diaz M, Lunte CE (1993). Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling. Pharm Res 10:44-48.
49. Thomsen M,Woldbye DP,Wortwein G, Fink-Jensen A,Wess J, Caine SB (2005). Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor- deficient mice. J Neurosci 25:8141-8149.
50. Thomsen M, Conn PJ, Lindsley C, Wess J, Boon JY, Fulton BS, et al. (2010). Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation. J Pharmacol Exp Ther 332:959-969.
51. Volkow ND, Fowler JS,Wang GJ, Hitzemann R, Logan J, Schlyer DJ, et al. (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177.
52. Volkow ND,Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, et al. (1997). Decreased striatal dopaminergic responsiveness in detoxified cocainedependent subjects. Nature 386:830-833.
53. Weiss F, Maldonado-Vlaar CS, Parsons LH, Kerr TM, Smith DL, Ben Shahar O (2000). Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc Natl Acad Sci U S A 97:4321-4326.
54. Weiss F, Martin-Fardon R, Ciccocioppo R, Kerr TM, Smith DL, Ben Shahar O (2001). Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues. Neuropsychopharm 25:361-372.
55. Williams MJ, Adinoff B (2008). The role of acetylcholine in cocaine addiction. Neuropsychopharm 33:1779-1797.
56. Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ, et al. (2005). A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100 (Suppl 1):68-77.